Table Of Content

1. Introduction

1.1 Market Definition

1.2 Scope (Inclusion and Exclusions)

1.3 Research Assumptions

2. Executive Summary

2.1 Market Overview

2.2 Regional Synopsis

2.3 Competitive Summary

3. Research Methodology

3.1 Top-Down Approach

3.2 Bottom-up Approach

3.3. Data Validation

3.4 Primary Interviews

4. Market Dynamics Impact Analysis

4.1 Market Driving Factors Analysis

4.1.1 Drivers

4.1.2 Restraints

4.1.3 Opportunities

4.1.4 Challenges

4.2 PESTLE Analysis

4.3 Porter’s Five Forces Model

5. Statistical Insights and Trends Reporting

5.1 Cancer Incidence and Prevalence (2024)

5.2 Gene Therapy Clinical Pipeline and Approvals (2024)

5.3 Adoption Trends by Therapy Type and Region (2020–2032)

5.4 Precision Oncology Prescription Patterns (2024)

5.5 Manufacturing & Supply Chain Capacity (2020–2032)

6. Competitive Landscape

6.1 List of Major Companies By Region

6.2 Market Share Analysis By Region

6.3 Product Benchmarking

6.3.1 Product specifications and features

6.3.2 Pricing

6.4 Strategic Initiatives

6.4.1 Marketing and promotional activities

6.4.2 Distribution and Supply Chain Strategies

6.4.3 Expansion plans and new product launches

6.4.4 Strategic partnerships and collaborations

6.5 Technological Advancements

6.6 Market Positioning and Branding

7. Cancer Gene Therapy Market Segmentation By Indication

7.1 Chapter Overview

7.2 Large B-Cell Lymphoma

7.2.1 Large B-Cell Lymphoma Market Trends Analysis (2021-2032)

7.2.2 Large B-Cell Lymphoma Market Size Estimates and Forecasts to 2032 (USD Billion)

7.3 Multiple Myeloma

7.3.1 Multiple Myeloma Market Trends Analysis (2021-2032)

7.3.2 Multiple Myeloma Market Size Estimates and Forecasts to 2032 (USD Billion)

7.4 Acute Lymphoblastic Leukemia (ALL)

7.4.1 Acute Lymphoblastic Leukemia (ALL) Market Trends Analysis (2021-2032)

7.4.2 Acute Lymphoblastic Leukemia (ALL) Market Size Estimates and Forecasts to 2032 (USD Billion)

7.5 Melanoma (lesions)

7.5.1 Melanoma (lesions) Market Trends Analysis (2021-2032)

7.5.2 Melanoma (lesions) Market Size Estimates and Forecasts to 2032 (USD Billion)

7.6 Others

7.6.1 Others Market Trends Analysis (2021-2032)

7.6.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)

8. Cancer Gene Therapy Market Segmentation By Route of Administration

8.1 Chapter Overview

8.2 Intravenous

8.2.1 Intravenous Market Trends Analysis (2021-2032)

8.2.2 Intravenous Market Size Estimates and Forecasts to 2032 (USD Billion)

8.3 Others

         8.3.1 Others Market Trends Analysis (2021-2032)

8.3.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)

9. Cancer Gene Therapy Market Segmentation By Vector Type

9.1 Chapter Overview

9.2 Lentivirus

9.2.1 Lentivirus Market Trends Analysis (2021-2032)

9.2.2 Lentivirus Market Size Estimates and Forecasts to 2032 (USD Billion)

9.3 RetroVirus & gamma RetroVirus

9.3.1 RetroVirus & gamma RetroVirus Market Trends Analysis (2021-2032)

9.3.2 RetroVirus & gamma RetroVirus Market Size Estimates and Forecasts to 2032 (USD Billion)

9.3 AAV

9.3.1 AAV Market Trends Analysis (2021-2032)

9.3.2 AAV Market Size Estimates and Forecasts to 2032 (USD Billion)

9.3 Modified Herpes Simplex Virus

9.3.1 Modified Herpes Simplex Virus Market Trends Analysis (2021-2032)

9.3.2 Modified Herpes Simplex Virus Market Size Estimates and Forecasts to 2032 (USD Billion)

9.3 Adenovirus

9.3.1 Adenovirus Market Trends Analysis (2021-2032)

9.3.2 Adenovirus Market Size Estimates and Forecasts to 2032 (USD Billion)

9.3 Others

9.3.1 Others Market Trends Analysis (2021-2032)

9.3.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)

10. Cancer Gene Therapy Market Segmentation by End-User

10.1 Chapter Overview

10.2 Cancer Research Institutes

10.2.1 Cancer Research Institutes Market Trends Analysis (2021-2032)

10.2.2 Cancer Research Institutes Market Size Estimates and Forecasts to 2032 (USD Billion)

10.3 Diagnostic Centers

10.3.1 Diagnostic Centers Market Trend Analysis (2021-2032)

10.3.2 Diagnostic Centers Market Size Estimates and Forecasts to 2032 (USD Billion)

10.4 Others (Hospitals and biotechnology Companies)

10.4.1 Others (Hospitals and biotechnology Companies) Market Trends Analysis (2021-2032)

10.4.2 Others (Hospitals and biotechnology Companies) Market Size Estimates and Forecasts to 2032 (USD Billion)

11. Regional Analysis

11.1 Chapter Overview

11.2 North America

11.2.1 Trend Analysis

11.2.2 North America Cancer Gene Therapy Market Estimates and Forecasts by Country (2021-2032) (USD Billion)

11.2.3 North America Cancer Gene Therapy Market Estimates and Forecasts by Indication (2021-2032) (USD Billion) 

11.2.4 North America Cancer Gene Therapy Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)

11.2.5 North America Cancer Gene Therapy Market Estimates and Forecasts by Vector Type (2021-2032) (USD Billion)

11.2.6 North America Cancer Gene Therapy Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)

11.2.7 USA

11.2.7.1 USA Cancer Gene Therapy Market Estimates and Forecasts by Indication (2021-2032) (USD Billion)

11.2.7.2 USA Cancer Gene Therapy Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)

11.2.7.3 USA Cancer Gene Therapy Market Estimates and Forecasts by Vector Type (2021-2032) (USD Billion)

11.2.7.4 USA Cancer Gene Therapy Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)

11.2.8 Canada

11.2.8.1 Canada Cancer Gene Therapy Market Estimates and Forecasts by Indication (2021-2032) (USD Billion)

11.2.8.2 Canada Cancer Gene Therapy Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)

11.2.8.3 Canada Cancer Gene Therapy Market Estimates and Forecasts by Vector Type (2021-2032) (USD Billion)

11.2.8.4 Canada Cancer Gene Therapy Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)

11.2.9 Mexico

11.2.9.1 Mexico Cancer Gene Therapy Market Estimates and Forecasts by Indication (2021-2032) (USD Billion)

11.2.9.2 Mexico Cancer Gene Therapy Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)

11.2.9.3 Mexico Cancer Gene Therapy Market Estimates and Forecasts by Vector Type (2021-2032) (USD Billion)

11.2.9.4 Mexico Cancer Gene Therapy Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)

11.3 Europe

11.3.1 Trend Analysis

11.3.2 Europe Cancer Gene Therapy Market Estimates and Forecasts by Country (2021-2032) (USD Billion)

11.3.3 Europe Cancer Gene Therapy Market Estimates and Forecasts by Indication (2021-2032) (USD Billion) 

11.3.4 Europe Cancer Gene Therapy Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)

11.3.5 Europe Cancer Gene Therapy Market Estimates and Forecasts by Vector Type (2021-2032) (USD Billion)

11.3.6 Europe Cancer Gene Therapy Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)

11.3.7 Germany

11.3.7.1 Germany Cancer Gene Therapy Market Estimates and Forecasts by Indication (2021-2032) (USD Billion)

11.3.7.2 Germany Cancer Gene Therapy Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)

11.3.7.3 Germany Cancer Gene Therapy Market Estimates and Forecasts by Vector Type (2021-2032) (USD Billion)

11.3.7.4 Germany Cancer Gene Therapy Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)

11.3.8 France

11.3.8.1 France Cancer Gene Therapy Market Estimates and Forecasts by Indication (2021-2032) (USD Billion)

11.3.8.2 France Cancer Gene Therapy Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)

11.3.8.3 France Cancer Gene Therapy Market Estimates and Forecasts by Vector Type (2021-2032) (USD Billion)

11.3.8.4 France Cancer Gene Therapy Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)

11.3.9 UK

11.3.9.1 UK Cancer Gene Therapy Market Estimates and Forecasts by Indication (2021-2032) (USD Billion)

11.3.9.2 UK Cancer Gene Therapy Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)

11.3.9.3 UK Cancer Gene Therapy Market Estimates and Forecasts by Vector Type (2021-2032) (USD Billion)

11.3.9.4 UK Cancer Gene Therapy Market Estimates and Forecasts by End-User  (2021-2032) (USD Billion)

11.3.10 Italy

11.3.10.1 ItalyCancer Gene Therapy Market Estimates and Forecasts by Indication (2021-2032) (USD Billion)

11.3.10.2 Italy Cancer Gene Therapy Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)

11.3.10.3 Italy Cancer Gene Therapy Market Estimates and Forecasts by Vector Type (2021-2032) (USD Billion)

11.3.10.4 Italy Cancer Gene Therapy Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)

11.3.11 Spain

11.3.11.1 Spain Cancer Gene Therapy Market Estimates and Forecasts by Indication (2021-2032) (USD Billion)

11.3.11.2 Spain Cancer Gene Therapy Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)

11.3.11.3 Spain Cancer Gene Therapy Market Estimates and Forecasts by Vector Type (2021-2032) (USD Billion)

11.3.11.4 Spain Cancer Gene Therapy Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)

11.3.12 Poland

11.3.12.1 Poland Cancer Gene Therapy Market Estimates and Forecasts by Indication (2021-2032) (USD Billion)

11.3.12.2 Poland Cancer Gene Therapy Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)

11.3.12.3 Poland Cancer Gene Therapy Market Estimates and Forecasts by Vector Type (2021-2032) (USD Billion)

11.3.12.4 Poland Cancer Gene Therapy Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)

11.3.13 Turkey

11.3.13.1 Turkey Cancer Gene Therapy Market Estimates and Forecasts by Indication (2021-2032) (USD Billion)

11.3.13.2 Turkey Cancer Gene Therapy Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)

11.3.13.3 Turkey Cancer Gene Therapy Market Estimates and Forecasts by Vector Type (2021-2032) (USD Billion)

11.3.13.4 Turkey Cancer Gene Therapy Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)

11.3.14 Rest of Europe

11.3.14.1 Rest of Europe Cancer Gene Therapy Market Estimates and Forecasts by Indication (2021-2032) (USD Billion)

11.3.14.2 Rest of Europe Cancer Gene Therapy Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)

11.3.14.3 Rest of Europe Cancer Gene Therapy Market Estimates and Forecasts by Vector Type (2021-2032) (USD Billion)

11.3.14.4 Rest of Europe Cancer Gene Therapy Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)

11.4 Asia Pacific

11.4.1 Trend Analysis

11.4.2 Asia Pacific Cancer Gene Therapy Market Estimates and Forecasts by Country (2021-2032) (USD Billion)

11.4.3 Asia Pacific Cancer Gene Therapy Market Estimates and Forecasts by Indication (2021-2032) (USD Billion) 

11.4.4 Asia Pacific Cancer Gene Therapy Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)

11.4.5 Asia Pacific Cancer Gene Therapy Market Estimates and Forecasts by Vector Type (2021-2032) (USD Billion)

11.4.6 Asia Pacific Cancer Gene Therapy Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)

11.4.7 China

11.4.7.1 China Cancer Gene Therapy Market Estimates and Forecasts by Indication (2021-2032) (USD Billion)

11.4.7.2 China Cancer Gene Therapy Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)

11.4.7.3 China Cancer Gene Therapy Market Estimates and Forecasts by Vector Type (2021-2032) (USD Billion)

11.4.7.4 China Cancer Gene Therapy Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)

11.4.8 India

11.4.8.1 India Cancer Gene Therapy Market Estimates and Forecasts by Indication (2021-2032) (USD Billion)

11.4.8.2 India Cancer Gene Therapy Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)

11.4.8.3 India Cancer Gene Therapy Market Estimates and Forecasts by Vector Type (2021-2032) (USD Billion)

11.4.8.4 India Cancer Gene Therapy Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)

11.4.9 Japan

11.4.9.1 Japan Cancer Gene Therapy Market Estimates and Forecasts by Indication (2021-2032) (USD Billion)

11.4.9.2 Japan Cancer Gene Therapy Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)

11.4.9.3 Japan Cancer Gene Therapy Market Estimates and Forecasts by Vector Type (2021-2032) (USD Billion)

11.4.9.4 Japan Cancer Gene Therapy Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)

11.4.10 South Korea

11.4.10.1 South Korea Cancer Gene Therapy Market Estimates and Forecasts by Indication (2021-2032) (USD Billion)

11.4.10.2 South Korea Cancer Gene Therapy Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)

11.4.10.3 South Korea Cancer Gene Therapy Market Estimates and Forecasts by Vector Type (2021-2032) (USD Billion)

11.4.10.4 South Korea Cancer Gene Therapy Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)

11.4.11 Singapore

11.4.11.1 Singapore Cancer Gene Therapy Market Estimates and Forecasts by Indication (2021-2032) (USD Billion)

11.4.11.2 Singapore Cancer Gene Therapy Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)

11.4.11.3 Singapore Cancer Gene Therapy Market Estimates and Forecasts by Vector Type (2021-2032) (USD Billion)

11.4.11.4 Singapore Cancer Gene Therapy Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)

11.4.12 Australia

11.4.12.1 Australia Cancer Gene Therapy Market Estimates and Forecasts by Indication (2021-2032) (USD Billion)

11.4.12.2 Australia Cancer Gene Therapy Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)

11.4.12.3 Australia Cancer Gene Therapy Market Estimates and Forecasts by Vector Type (2021-2032) (USD Billion)

11.4.12.4 Australia Cancer Gene Therapy Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)

11.4.13 Rest of Asia Pacific

11.4.13.1 Rest of Asia Pacific Cancer Gene Therapy Market Estimates and Forecasts by Indication (2021-2032) (USD Billion)

11.4.13.2 Rest of Asia Pacific Cancer Gene Therapy Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)

11.4.13.3 Rest of Asia Pacific Cancer Gene Therapy Market Estimates and Forecasts by Vector Type (2021-2032) (USD Billion)

11.4.13.4 Rest of Asia Pacific Cancer Gene Therapy Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)

11.5 Middle East and Africa

11.5.1 Trend Analysis

11.5.2 Middle East and Africa Cancer Gene Therapy Market Estimates and Forecasts by Country (2021-2032) (USD Billion)

11.5.3 Middle East and Africa Cancer Gene Therapy Market Estimates and Forecasts by Indication (2021-2032) (USD Billion) 

11.5.4 Middle East and Africa Cancer Gene Therapy Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)

11.5.5 Middle East and Africa Cancer Gene Therapy Market Estimates and Forecasts by Vector Type (2021-2032) (USD Billion)

11.5.6 Middle East and Africa Cancer Gene Therapy Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)

11.5.7 UAE

11.5.7.1 UAE Cancer Gene Therapy Market Estimates and Forecasts by Indication (2021-2032) (USD Billion)

11.5.7.2 UAE Cancer Gene Therapy Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)

11.5.7.3 UAE Cancer Gene Therapy Market Estimates and Forecasts by Vector Type (2021-2032) (USD Billion)

11.5.7.4 UAE Cancer Gene Therapy Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)

11.5.8 Saudi Arabia

11.5.8.1 Saudi Arabia Cancer Gene Therapy Market Estimates and Forecasts by Indication (2021-2032) (USD Billion)

11.5.8.2 Saudi Arabia Cancer Gene Therapy Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)

11.5.8.3 Saudi Arabia Cancer Gene Therapy Market Estimates and Forecasts by Vector Type (2021-2032) (USD Billion)

11.5.8.4 Saudi Arabia Cancer Gene Therapy Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)

11.5.9 Qatar

                     11.5.9.1 Qatar Cancer Gene Therapy Market Estimates and Forecasts by Indication (2021-2032) (USD Billion)

11.5.9.2 Qatar Cancer Gene Therapy Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)

11.5.9.3 Qatar Cancer Gene Therapy Market Estimates and Forecasts by Vector Type (2021-2032) (USD Billion)

11.5.1.9.4 Qatar Cancer Gene Therapy Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)

11.5.10   South Africa

11.5.10.1 South Africa Cancer Gene Therapy Market Estimates and Forecasts by Indication (2021-2032) (USD Billion)

11.5.10.2 South Africa Cancer Gene Therapy Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)

11.5.10.3 South Africa Cancer Gene Therapy Market Estimates and Forecasts by Vector Type (2021-2032) (USD Billion)

11.5.10.4 South Africa Cancer Gene Therapy Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)

11.5.11 Rest of Middle East & Africa

                    11.5.11.1 Rest of Middle East & Africa Cancer Gene Therapy Market Estimates and Forecasts by Indication (2021-2032) (USD Billion)

11.5.11.2 Rest of Middle East & Africa  Cancer Gene Therapy Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)

11.5.11.3 Rest of Middle East & Africa Cancer Gene Therapy Market Estimates and Forecasts by Vector Type (2021-2032) (USD Billion)

11.5.11.4 Rest of Middle East & Africa Cancer Gene Therapy Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)

11.6 Latin America

11.6.1 Trend Analysis

11.6.2 Latin America Cancer Gene Therapy Market Estimates and Forecasts by Country (2021-2032) (USD Billion)

11.6.3 Latin America Cancer Gene Therapy Market Estimates and Forecasts by Indication (2021-2032) (USD Billion) 

11.6.4 Latin America Cancer Gene Therapy Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)

11.6.5 Latin America Cancer Gene Therapy Market Estimates and Forecasts by Vector Type (2021-2032) (USD Billion)

11.6.6 Latin America Cancer Gene Therapy Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)

11.6.7 Brazil

11.6.7.1 Brazil Cancer Gene Therapy Market Estimates and Forecasts by Indication (2021-2032) (USD Billion)

11.6.7.2 Brazil Cancer Gene Therapy Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)

11.6.7.3 Brazil Cancer Gene Therapy Market Estimates and Forecasts by Vector Type (2021-2032) (USD Billion)

11.6.7.4 Brazil Cancer Gene Therapy Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)

11.6.8 Argentina

11.6.8.1 Argentina Cancer Gene Therapy Market Estimates and Forecasts by Indication (2021-2032) (USD Billion)

11.6.8.2 Argentina Cancer Gene Therapy Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)

11.6.8.3 Argentina Cancer Gene Therapy Market Estimates and Forecasts by Vector Type (2021-2032) (USD Billion)

11.6.8.4 Argentina Cancer Gene Therapy Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)

11.6.9 Rest of Latin America

11.6.9.1 Rest of Latin America Cancer Gene Therapy Market Estimates and Forecasts by Indication (2021-2032) (USD Billion)

11.6.9.2 Rest of Latin America Cancer Gene Therapy Market Estimates and Forecasts by Route of Administration (2021-2032) (USD Billion)

11.6.9.3 Rest of Latin America Cancer Gene Therapy Market Estimates and Forecasts by Vector Type (2021-2032) (USD Billion)

11.6.9.4 Rest of Latin America Cancer Gene Therapy Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)

12. Company Profiles

12.1 OncoGenex Pharmaceuticals Inc.,

          12.1.1 Company Overview

12.1.2 Financial

12.1.3 Products/ Services Offered

12.1.4 SWOT Analysis

12.2 Merck KGaA,

           12.2.1 Company Overview

12.2.2 Financial

12.2.3 Products/ Services Offered

12.2.4 SWOT Analysis

12.3 Introgen Therapeutics Inc.,            

          12.3.1 Company Overview

12.3.2 Financial

12.3.3 Products/ Services Offered

12.3.4 SWOT Analysis

12.4 GSK plc (GlaxoSmithKline)

          12.4.1 Company Overview

12.4.2 Financial

12.4.3 Products/ Services Offered

12.4.4 SWOT Analysis

12.5 GenVec

          12.5.1 Company Overview

12.5.2 Financial

12.5.3 Products/ Services Offered

12.5.4 SWOT Analysis

12.6 Genelux Corporation

            12.6.1 Company Overview

12.6.2 Financial

12.6.3 Products/ Services Offered

12.6.4 SWOT Analysis

12.7 Elevate Bio Inc

          12.7.1 Company Overview

12.7.2 Financial

12.7.3 Products/ Services Offered

12.7.4 SWOT Analysis

12.8 Celgene Inc.,

12.8.1 Company Overview

12.8.2 Financial

12.8.3 Products/ Services Offered

12.8.4 SWOT Analysis

12.9 Bluebird Bio Inc.,

12.9.1 Company Overview

12.9.2 Financial

12.9.3 Products/ Services Offered

12.9.4 SWOT Analysis

12.10 BioCancell Inc

12.10.1 Company Overview

12.10.2 Financial

12.10.3 Products/ Services Offered

12.10.4 SWOT Analysis

13. Use Cases and Best Practices

14. Conclusion